Condizioni

16 condizioni di salute con ricerca sugli integratori basata sulle evidenzecondizioni di salute con ricerca sugli integratori basata sulle evidenze

We evaluate supplements across specific hair and scalp conditions. Each condition page ranks ingredients by evidence grade, helping you find what research actually supports for your particular concern.

How We Grade Evidence

Ogni pagina dedicata a una condizione classifica gli ingredienti degli integratori in base alla solidità delle evidenze cliniche. Ecco il significato di ciascun grado:

Strong Evidence

Multiple randomized controlled trials (RCTs) or meta-analyses with consistent positive results and large sample sizes.

Good Evidence

At least one RCT with mostly consistent results across studies. Evidence suggests benefit but more research may be needed.

Some Evidence

Small studies or observational data with some positive signals. Promising but insufficient for strong recommendations.

Very Early Research

In vitro studies, case reports, or pilot studies only. Early-stage research that requires clinical validation.

Alopecia androgenetica

50% of men by age 50, 25% of women by age 50

Receding hairline Crown thinning Widening part +1

Alopecia areata

2% lifetime risk

Circular bald patches Exclamation point hairs Nail pitting

Alopecia da trazione

Common in certain hairstyle practices

Hairline recession Broken hairs Folliculitis

Alopecia femminile

40% of women by age 50

Widening central part Diffuse crown thinning Preserved frontal hairline

Diradamento dei capelli legato all'età

Near-universal over age 60

Gradual density reduction Finer hair texture Slower growth rate

Perdita di capelli da carenza di ferro

Affects up to 60% of premenopausal women with hair loss

Diffuse thinning Increased shedding Fatigue +1

Perdita di capelli da carenza nutrizionale

Common in restrictive diets and malabsorption conditions

Diffuse thinning Dry dull hair Slow growth +1

Perdita di capelli da psoriasi del cuoio capelluto

45-56% of psoriasis patients have scalp involvement

Thick scales Red patches Itching +1

Perdita di capelli da stress

Increasingly common; associated with telogen effluvium

Diffuse shedding Hair thinning Slower regrowth

Perdita di capelli legata alla tiroide

4-10% of general population has thyroid dysfunction

Diffuse thinning Dry brittle hair Loss of outer eyebrows

Perdita di capelli post-partum

Affects 40-50% of women postpartum

Excessive shedding Thinning around temples Reduced hair density

Telogen effluvium

Second most common cause of hair loss

Diffuse thinning Excessive shedding Reduced ponytail volume

Chemotherapy-Induced Hair Loss

Affects 65-85% of chemotherapy patients depending on regimen

Rapid diffuse shedding Complete scalp hair loss Eyebrow and eyelash loss +1

Hormonal Hair Changes (PCOS & Menopause)

PCOS affects 6-12% of women; menopause-related thinning affects 40%+ of postmenopausal women

Diffuse thinning Changes in hair texture Hirsutism (PCOS) +1

Brittle Hair and Nails Syndrome

Affects approximately 20% of the general population

Dry, splitting hair Increased breakage Brittle, peeling nails +1

Scalp Inflammation (Folliculitis & Dermatitis)

Seborrheic dermatitis affects 3-5% of adults; scalp involvement very common

Scalp redness Itching and flaking Pustules around follicles +1

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.